ANGPTL3 and neoplasm: However, the different xenografts on the left and the right sides of the same mouse showed different response to sorafenib under the same blood ANGPTL3 concentration (Fig. 3e), suggesting that the ANGPTL3 in the bloodstream may not be the main factor influencing the response of tumour cells to sorafenib.